2022 ASCO Gastrointestinal Cancers Symposium
TOPAZ-1 Trial: Durvalumab and Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
TOPAZ-1 Trial: Durvalumab and Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer